(MedPage Today) -- Waiting to treat cytomegalovirus (CMV) in kidney transplant patients may deliver better long-term outcomes than blanket preventive drugs, researchers found. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment